New hope for hidden arthritis pain: phase 3 trial launches
NCT ID NCT07349329
First seen Jan 17, 2026 · Last updated May 22, 2026 · Updated 13 times
Summary
This study tests a new drug called 608 for people with a type of arthritis in the spine that doesn't show up on X-rays (non-radiographic axial spondyloarthritis). The goal is to see if 608 can reduce pain and improve function better than a placebo. About 380 adults will take part, and the main measure is a 40% improvement in symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AXIAL SPONDYLOARTHRITIS, NON-RADIOGRAPHIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site 01
Beijing, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.